SEC Form 4 · accession 0001209191-17-029470
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory M Weinhoff
Officer — Principal Financial Officer
Period of report
Apr 28, 2017
Accepted (ET)
May 2, 2017 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2,F1 | $24.24 | Apr 28, 2017 | A | 175,000 | A | — | Apr 28, 2027 | Common Shares | 175,000 | 175,000 | D |
| Employee Stock Option (Right to Buy)F3 | $16.49 | holding | — | — | — | — | Sep 15, 2025 | Common Shares | 295,938 | 295,938 | D |
| Employee Stock Option (Right to Buy)F4,F3 | $16.49 | holding | — | — | — | — | Sep 15, 2025 | Common Shares | 158,158 | 158,158 | I |
Explanation of responses
- F1This option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 28, 2018 and the remainder vesting in twelve equal quarterly installments thereafter. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- F2Includes only options with the same termination date.
- F3This option vests over a period of four years, with one quarter of the common shares underlying the option vesting August 10, 2016 and the remainder vesting in twelve equal installments on a quarterly basis thereafter. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in issuer's 2015 Equity Incentive Plan.
- F4These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney